Is Pfizer (PFE) a value trap for investors?
Is Pfizer (PFE) a value trap for investors?
(via dividendgrowth.blogspot.com)
The company is a dividend aristocrat as well as a component of the S&P 500 and Dow Jones Industrials indexes. It has been increasing its dividends for the past 41 consecutive years. From 1998 up until 2007 this dividend growth stock has delivered an annual average total return of 1.1 % to its shareholders. The stock has lost more than 63% from its all-time-high of $50 in 1999 however.

